- 88 Downloads
Percutaneous revascularization is a widely accepted procedure to treat patients with coronary artery disease. Since its first description in the 1970s, significant technological and pharmaceutical advances have occurred and subsequently reduced the complications associated with the procedure. Large, randomized controlled trials have provided additional evidence that percutaneous revascularization improves morbidity and mortality in patients with coronary artery disease. Over the last decade, devices designed to treat patients with more complex coronary artery disease have expanded the available therapeutic options and will likely contribute to a further decline in adverse events. Despite these advances, the management of patients with acute myocardial infarction, in-stent restenosis, and multivessel coronary artery disease remains challenging. The majority of evidence supports an early, aggressive approach in patients with acute ST-elevation and non-ST-elevation myocardial infarction. Ongoing clinical trials should help to further define the role of percutaneous interventions in the optimal management of patients with coronary artery disease.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 14.Ellis SG, Cowley MJ, Whitlow PL, et al.: Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986–1987 versus 1991: improved in-hospital and 12-month results. Multivessel Angioplasty Prognosis Study (MAPS) Group. J Am Coll Cardiol 1995, 25:1137–1142.PubMedCrossRefGoogle Scholar
- 15.Hillegass WB, Califf RM: Restenosis: the clinical issues. In Textbook of Interventional Cardiology. Edited by Topol EJ. Philadelphia, PA: WB Saunders Company;1994:415–435.Google Scholar
- 25.Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators [no authors listed]. N Engl J Med 1996, 335:217–225. [Published erratum appears in N Engl J Med 1997, 336:147.]Google Scholar
- 26.Bentivoglio LG, Detre K, Yeh W, et al.: Outcome of percutaneous transluminal coronary angioplasty in subsets of unstable angina pectoris. A report of the 1985–1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol 1994, 24:1195–1206.PubMedCrossRefGoogle Scholar
- 27.Boden WE, O’Rourke RA, Crawford MH, et al.: Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigator. N Engl J Med 1998, 338:1785–1792. [Published erratum appears in N Engl J Med 1998, 339:1091.]PubMedCrossRefGoogle Scholar
- 28.Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Fragmin and Fast Revascularisation during Instability in Coronary artery disease Investigators [no authors listed]. Lancet 1999, 354:708–715.Google Scholar
- 30.Weaver WD, Simes RJ, Betriu A, et al.: Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997, 278:2093–2098. [Published erratum appears in JAMA 1998, 279:1876.]. Meta-analysis of 10 randomized trials comparing the use of PTCA or thrombolytic therapy in patients with acute MI.PubMedCrossRefGoogle Scholar
- 31.Antoniucci D, Santoro GM, Bolognese L, et al.: A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. J Am Coll Cardiol 1998, 31:1234–1239.PubMedCrossRefGoogle Scholar
- 34.Anderson HR: The Danish Multicenter Randomized Study on Thrombolytic Therapy versus Acute Coronary Angioplasty in Acute Myocardial Infarction-2 (DANAMI-2). Paper presented at the ACC 51st Annual Scientific Session. Atlanta, GA; March 20, 2002.Google Scholar
- 38.Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators [no authors listed]. N Engl J Med 1997, 336:1689–1696.Google Scholar
- 39.Kong DF, Califf RM, Miller DP, et al.: Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation 1998, 98:2829–2835. Meta-analysis of randomized GP IIb/IIIa inhibitor trials demonstrating clinical benefit in patients with acute coronary syndromes.PubMedGoogle Scholar
- 41.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation. The CURE Investigators [no authors listed]. N Engl J Med 2001, 345:494–502.Google Scholar